Lymphocytes and autoimmunity after spinal cord injury

Experimental Neurology

Volumn 258, Issue , 2014, Pages 78-90

  Jones, T Bucky ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Adaptive immunity; Autoantibodies; Autoimmunity; B lymphocytes; Effector T lymphocytes; Regulatory T cells; Spinal cord injury

Indexed keywords

EPITOPE; MYELIN; AUTOANTIBODY;

ACTIVE IMMUNIZATION; ADAPTIVE IMMUNITY; AUTOIMMUNITY; B LYMPHOCYTE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC MANIPULATION; HUMAN; LYMPHOCYTE PROLIFERATION; NEUROPROTECTION; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SPINAL CORD INJURY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSLATION REGULATION; ANIMAL; EFFECTOR T-LYMPHOCYTES; IMMUNOLOGY; LYMPHOCYTE; METHODOLOGY; PATHOLOGY; REGULATORY T-CELLS; VACCINATION;

ADAPTIVE IMMUNITY; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; EFFECTOR T-LYMPHOCYTES; REGULATORY T-CELLS; SPINAL CORD INJURY;

ANIMALS; AUTOIMMUNITY; HUMANS; LYMPHOCYTES; SPINAL CORD INJURIES; VACCINATION;

EID: 84904737134     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.03.003     Document Type: Review

References (180)

1. Aharoni R., Teitelbaum D., Sela M., Arnon R. Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1. J. Neuroimmunol. 1998, 91:135-146.
2. Aharoni R., Teitelbaum D., Leitner O., Meshorer A., Sela M., Arnon R. Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:11472-11477.
3. Aktas O., Smorodchenko A., Brocke S., Infante-Duarte C., Schulze TopphoffU., Vogt J., Prozorovski T., Meier S., Osmanova V., Pohl E., Bechmann I., Nitsch R., Zipp F. Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL. Neuron 2005, 46:421-432.
4. Angelov D.N., Waibel S., Guntinas-Lichius O., Lenzen M., Neiss W.F., Tomov T.L., Yoles E., Kipnis J., Schori H., Reuter A., Ludolph A., Schwartz M. Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:4790-4795.
5. Ankeny D.P., Popovich P.G. B cells and autoantibodies: complex roles in CNS injury. Trends Immunol. 2010, 31:332-338.
6. Ankeny D.P., Lucin K.M., Sanders V.M., McGaughy V.M., Popovich P.G. Spinal cord injury triggers systemic autoimmunity: evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis. J. Neurochem. 2006, 99:1073-1087.
7. Ankeny D.P., Guan Z., Popovich P.G. B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice. J. Clin. Invest. 2009, 119:2990-2999.
8. Antel J.P., Williams K., Blain M., McRea E., McLaurin J. Oligodendrocyte lysis by CD4+ T cells independent of tumor necrosis factor. Ann. Neurol. 1994, 35:341-348.
9. Arnold S.A., Hagg T. Anti-inflammatory treatments during the chronic phase of spinal cord injury improve locomotor function in adult mice. J. Neurotrauma 2011, 28:1995-2002.
10. Barouch R., Schwartz M. Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity. FASEB J. 2002, 16:1304-1306.
11. Basso D.M., Fisher L.C., Anderson A.J., Jakeman L.B., McTigue D.M., Popovich P.G. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma 2006, 23:635-659.
12. Beck K.D., Nguyen H.X., Galvan M.D., Salazar D.L., WoodruffT.M., Anderson A.J. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain 2010, 133:433-447.
13. Becker K., Kindrick D., McCarron R., Hallenbeck J., Winn R. Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury?. Stroke 2003, 34:1809-1815.
14. Beers D.R., Henkel J.S., Zhao W., Wang J., Huang A., Wen S., Liao B., Appel S.H. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain 2011, 134:1293-1314.
15. Benner E.J., Mosley R.L., Destache C.J., Lewis T.B., Jackson-Lewis V., Gorantla S., Nemachek C., Green S.R., Przedborski S., Gendelman H.E. Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:9435-9440.
16. Bethea J.R., Nagashima H., Acosta M.C., Briceno C., Gomez F., Marcillo A.E., Loor K., Green J., Dietrich W.D. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma 1999, 16:851-863.
17. Bielekova B., Catalfamo M., Reichert-Scrivner S., Packer A., Cerna M., Waldmann T.A., McFarland H., Henkart P.A., Martin R. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:5941-5946.
18. Butovsky O., Hauben E., Schwartz M. Morphological aspects of spinal cord autoimmune neuroprotection: colocalization of T cells with B7-2 (CD86) and prevention of cyst formation. FASEB J. 2001, 15(6):1065-1067. 10.1096/fj.00-0550fje.
19. Butovsky O., Koronyo-Hamaoui M., Kunis G., Ophir E., Landa G., Cohen H., Schwartz M. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:11784-11789.
20. Cao C., Arendash G.W., Dickson A., Mamcarz M.B., Lin X., Ethell D.W. Abeta-specific Th2 cells provide cognitive and pathological benefits to Alzheimer's mice without infiltrating the CNS. Neurobiol. Dis. 2009, 34:63-70.
21. Chen L., Flies D.B. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 2013, 13:227-242.
22. Chen S., Wu H., Klebe D., Hong Y., Zhang J., Tang J. Regulatory T cell in stroke: a new paradigm for immune regulation. Clin. Dev. Immunol. 2013, 2013:689827.
23. Davies A.L., Hayes K.C., Dekaban G.A. Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury. Arch. Phys. Med. Rehabil. 2007, 88:1384-1393.
24. Davtyan H., Ghochikyan A., Petrushina I., Hovakimyan A., Davtyan A., Poghosyan A., Marleau A.M., Movsesyan N., Kiyatkin A., Rasool S., Larsen A.K., Madsen P.J., Wegener K.M., Ditlevsen D.K., Cribbs D.H., Pedersen L.O., Agadjanyan M.G. Immunogenicity, efficacy, safety, and mechanism of action of epitope vaccine (Lu AF20513) for Alzheimer's disease: prelude to a clinical trial. J. Neurosci. 2013, 33:4923-4934.
25. Dayan C.M., Wraith D.C. Preparing for first-in-man studies: the challenges for translational immunology post-TGN1412. Clin. Exp. Immunol. 2008, 151:231-234.
26. Delgado M., Chorny A., Gonzalez-Rey E., Ganea D. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo. J. Leukoc. Biol. 2005, 78:1327-1338.
27. Delrieu J., Ousset P.J., Caillaud C., Vellas B. 'Clinical trials in Alzheimer's disease': immunotherapy approaches. J. Neurochem. 2012, 120(Suppl. 1):186-193.
28. Ebner F., Brandt C., Thiele P., Richter D., Schliesser U., Siffrin V., Schueler J., Stubbe T., Ellinghaus A., Meisel C., Sawitzki B., Nitsch R. Microglial activation milieu controls regulatory T cell responses. J. Immunol. 2013, 191:5594-5602.
29. Edling A.E., Nanavati T., Johnson J.M., Tuohy V.K. Human and murine lymphocyte neurotrophin expression is confined to B cells. J. Neurosci. Res. 2004, 77:709-717.
30. Filli L., Schwab M.E. The rocky road to translation in spinal cord repair. Ann. Neurol. 2012, 72:491-501.
31. Fitch M.T., Silver J. CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp. Neurol. 2008, 209:294-301.
32. Frenkel D., Huang Z., Maron R., Koldzic D.N., Moskowitz M.A., Weiner H.L. Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J. Neurol. Sci. 2005, 233:125-132.
33. Fruman D.A., Klee C.B., Bierer B.E., BurakoffS.J. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:3686-3690.
34. Fujio K., Okamura T., Yamamoto K. The family of IL-10-secreting CD4+ T cells. Adv. Immunol. 2010, 105:99-130.
35. Furtado G.C., Curotto de Lafaille M.A., Kutchukhidze N., Lafaille J.J. Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J. Exp. Med. 2002, 196:851-857.
36. Ganguly D., Haak S., Sisirak V., Reizis B. The role of dendritic cells in autoimmunity. Nat. Rev. Immunol. 2013, 13:566-577.
37. Garcia E., Silva-Garcia R., Mestre H., Flores N., Martinon S., Calderon-Aranda E.S., Ibarra A. Immunization with A91 peptide or copolymer-1 reduces the production of nitric oxide and inducible nitric oxide synthase gene expression after spinal cord injury. J. Neurosci. Res. 2012, 90:656-663.
38. Genain C.P., Abel K., Belmar N., Villinger F., Rosenberg D.P., Linington C., Raine C.S., Hauser S.L. Late complications of immune deviation therapy in a nonhuman primate. Science 1996, 274:2054-2057.
39. Gensel J.C., Nakamura S., Guan Z., van Rooijen N., Ankeny D.P., Popovich P.G. Macrophages promote axon regeneration with concurrent neurotoxicity. J. Neurosci. 2009, 29:3956-3968.
40. Gimsa U., Peter S.V., Lehmann K., Bechmann I., Nitsch R. Axonal damage induced by invading T cells in organotypic central nervous system tissue in vitro: involvement of microglial cells. Brain Pathol. 2000, 10:365-377.
41. Giuliani F., Goodyer C.G., Antel J.P., Yong V.W. Vulnerability of human neurons to T cell-mediated cytotoxicity. J. Immunol. 2003, 171:368-379.
42. Gonzenbach R.R., Schwab M.E. Disinhibition of neurite growth to repair the injured adult CNS: focusing on Nogo. Cell. Mol. Life Sci. 2008, 65:161-176.
43. Gorantla S., Liu J., Wang T., Holguin A., Sneller H.M., Dou H., Kipnis J., Poluektova L., Gendelman H.E. Modulation of innate immunity by copolymer-1 leads to neuroprotection in murine HIV-1 encephalitis. Glia 2008, 56:223-232.
44. Ha D., Stone D.K., Mosley R.L., Gendelman H.E. Immunization strategies for Parkinson's disease. Parkinsonism Relat. Disord. 2012, 18(Suppl. 1):S218-S221.
45. Hammarberg H., Lidman O., Lundberg C., Eltayeb S.Y., Gielen A.W., Muhallab S., Svenningsson A., Linda H., Der Meide P.H., Cullheim S., Olsson T., Piehl F. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J. Neurosci. 2000, 20:5283-5291.
46. Hara H., Mouri A., Yonemitsu Y., Nabeshima T., Tabira T. Mucosal immunotherapy in an Alzheimer mouse model by recombinant Sendai virus vector carrying Abeta1-43/IL-10 cDNA. Vaccine 2011, 29:7474-7482.
47. Hauben E., Butovsky O., Nevo U., Yoles E., Moalem G., Agranov E., Mor F., Leibowitz-Amit R., Pevsner E., Akselrod S., Neeman M., Cohen I.R., Schwartz M. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J. Neurosci. 2000, 20:6421-6430.
48. Hauben E., Nevo U., Yoles E., Moalem G., Agranov E., Mor F., Akselrod S., Neeman M., Cohen I.R., Schwartz M. Autoimmune T cells as potential neuroprotective therapy for spinal cord injury [letter]. Lancet 2000, 355:286-287.
49. Hauben E., Agranov E., Gothilf A., Nevo U., Cohen A., Smirnov I., Steinman L., Schwartz M. Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease. J. Clin. Invest. 2001, 108:591-599.
50. Hauben E., Ibarra A., Mizrahi T., Barouch R., Agranov E., Schwartz M. Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:15173-15178.
51. Hauben E., Mizrahi T., Agranov E., Schwartz M. Sexual dimorphism in the spontaneous recovery from spinal cord injury: a gender gap in beneficial autoimmunity?. Eur. J. Neurosci. 2002, 16:1731-1740.
52. Hauben E., Gothilf A., Cohen A., Butovsky O., Nevo U., Smirnov I., Yoles E., Akselrod S., Schwartz M. Vaccination with dendritic cells pulsed with peptides of myelin basic protein promotes functional recovery from spinal cord injury. J. Neurosci. 2003, 23:8808-8819.
53. Hawryluk G.W., Rowland J., Kwon B.K., Fehlings M.G. Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury. Neurosurg. Focus 2008, 25:E14.
54. Hayes K.C., Hull T.C., Delaney G.A., Potter P.J., Sequeira K.A., Campbell K., Popovich P.G. Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury. J. Neurotrauma 2002, 19:753-761.
55. Henkel J.S., Beers D.R., Wen S., Rivera A.L., Toennis K.M., Appel J.E., Zhao W., Moore D.H., Powell S.Z., Appel S.H. Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol. Med. 2013, 5:64-79.
56. Hong J., Li N., Zhang X., Zheng B., Zhang J.Z. Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:6449-6454.
57. Howe C.L., Bieber A.J., Warrington A.E., Pease L.R., Rodriguez M. Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody. Neurobiol. Dis. 2004, 15:120-131.
58. Hu J.G., Shen L., Wang R., Wang Q.Y., Zhang C., Xi J., Ma S.F., Zhou J.S., Lu H.Z. Effects of olig2-overexpressing neural stem cells and myelin basic protein-activated T cells on recovery from spinal cord injury. Neurotherapeutics 2012, 9:422-445.
59. Huang D.W., McKerracher L., Braun P.E., David S. A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord. Neuron 1999, 24:639-647.
60. Huang Z., Meola D., Petitto J.M. Loss of CNS IL-2 gene expression modifies brain T lymphocyte trafficking: response of normal versus autoreactive Treg-deficient T cells. Neurosci. Lett. 2011, 499:213-218.
61. Huang Z.Y., Hunter S., Chien P., Kim M.K., Han-Kim T.H., Indik Z.K., Schreiber A.D. Interaction of two phagocytic host defense systems: Fcgamma receptors and complement receptor 3. J. Biol. Chem. 2011, 286:160-168.
62. Ibarra A., Martinez S., Reyes J., Meza-Lucas A., Mandujano A., Grijalva I., Madrazo I., Correa D. Search for an IgG response against neural antigens in experimental spinal cord injury. Neuroscience 2000, 96:3-5.
63. Ibarra A., Correa D., Willms K., Merchant M.T., Guizar-Sahagun G., Grijalva I., Madrazo I. Effects of cyclosporin-A on immune response, tissue protection and motor function of rats subjected to spinal cord injury. Brain Res. 2003, 979:165-178.
64. Ibarra A., Jimenez A., Cortes C., Correa D. Influence of the intensity, level and phase of spinal cord injury on the proliferation of T cells and T-cell-dependent antibody reactions in rats. Spinal Cord 2007, 45:380-386.
65. Ibarra A., García E., Flores N., Martiñón S., Reyes R., Campos M.G., Maciel M., Mestre H. Immunization with neural-derived antigens inhibits lipid peroxidation after spinal cord injury. Neurosci. Lett. 2010, 476(2):62-65. 10.1016/j.neulet.2010.04.003.
66. Ibarra A., Sosa M., Garcia E., Flores A., Cruz Y., Mestre H., Martinon S., Pineda-Rodriguez B.A., Gutierrez-Ospina G. Prophylactic neuroprotection with A91 improves the outcome of spinal cord injured rats. Neurosci. Lett. 2013, 554:59-63.
67. Ishii H., Jin X., Ueno M., Tanabe S., Kubo T., Serada S., Naka T., Yamashita T. Adoptive transfer of Th1-conditioned lymphocytes promotes axonal remodeling and functional recovery after spinal cord injury. Cell Death Dis. 2012, 3:e363.
68. Jones T.B., Basso D.M., Sodhi A., Pan J.Z., Hart R.P., MacCallum R.C., Lee S., Whitacre C.C., Popovich P.G. Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J. Neurosci. 2002, 22:2690-2700.
69. Jones T.B., Ankeny D.P., Guan Z., McGaughy V., Fisher L.C., Basso D.M., Popovich P.G. Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats. J. Neurosci. 2004, 24:3752-3761.
70. Jones T.B., Hart R.P., Popovich P.G. Molecular control of physiological and pathological T-cell recruitment after mouse spinal cord injury. J. Neurosci. 2005, 25:6576-6583.
71. Kahn N.N., Bauman W.A., Sinha A.K. Appearance of a novel prostacyclin receptor antibody and duration of spinal cord injury. J. Spinal Cord Med. 2005, 28:97-102.
72. Kala M., Rhodes S.N., Piao W.H., Shi F.D., Campagnolo D.I., Vollmer T.L. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis. Exp. Neurol. 2010, 221:136-145.
73. Kappos L., Radue E.W., O'Connor P., Polman C., Hohlfeld R., Calabresi P., Selmaj K., Agoropoulou C., Leyk M., Zhang-Auberson L., Burtin P., Group, F.S. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N. Engl. J. Med. 2010, 362:387-401.
74. Karnezis T., Mandemakers W., McQualter J.L., Zheng B., Ho P.P., Jordan K.A., Murray B.M., Barres B., Tessier-Lavigne M., Bernard C.C. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat. Neurosci. 2004, 7:736-744.
75. Karran E. Current status of vaccination therapies in Alzheimer's disease. J. Neurochem. 2012, 123:647-651.
76. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 2009, 29:13435-13444.
77. Kil K., Zang Y.C., Yang D., Markowski J., Fuoco G.S., Vendetti G.C., Rivera V.M., Zhang J.Z. T cell responses to myelin basic protein in patients with spinal cord injury and multiple sclerosis. J. Neuroimmunol. 1999, 98:201-207.
78. Kipnis J., Yoles E., Porat Z., Cohen A., Mor F., Sela M., Cohen I.R., Schwartz M. T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:7446-7451.
79. Kipnis J., Yoles E., Mizrahi T., Ben Nur A., Schwartz M. Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity. J. Neuroimmunol. 2002, 130:78.
80. Korn T., Anderson A.C., Bettelli E., Oukka M. The dynamics of effector T cells and Foxp3+ regulatory T cells in the promotion and regulation of autoimmune encephalomyelitis. J. Neuroimmunol. 2007, 191:51-60.
81. Kwon B.K., Okon E.B., Tsai E., Beattie M.S., Bresnahan J.C., Magnuson D.K., Reier P.J., McTigue D.M., Popovich P.G., Blight A.R., Oudega M., Guest J.D., Weaver L.C., Fehlings M.G., TetzlaffW. A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury. J. Neurotrauma 2011, 28(8):1525-1543.
82. Kwon B.K., Ghag A., Reichl L., Dvorak M.F., Illes J., TetzlaffW. Opinions on the preclinical evaluation of novel therapies for spinal cord injury: a comparison between researchers and spinal cord-injured individuals. J. Neurotrauma 2012, 29:2367-2374.
83. Lacan G., Dang H., Middleton B., Horwitz M.A., Tian J., Melega W.P., Kaufman D.L. Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. J. Neurosci. Res. 2013, 91:1292-1302.
84. Lambracht-Washington D., Rosenberg R.N. Active DNA Abeta42 vaccination as immunotherapy for Alzheimer disease. Transl. Neurosci. 2012, 3:307-313.
85. Lapchak P.A., Zhang J.H., Noble-Haeusslein L.J. RIGOR guidelines: escalating STAIR and STEPS for effective translational research. Transl. Stroke Res. 2013, 4:279-285.
86. Lee K.D., Chow W.N., Sato-Bigbee C., Graf M.R., Graham R.S., Colello R.J., Young H.F., Mathern B.E. FTY720 reduces inflammation and promotes functional recovery after spinal cord injury. J. Neurotrauma 2009, 26:2335-2344.
87. Liesz A., Suri-Payer E., Veltkamp C., Doerr H., Sommer C., Rivest S., Giese T., Veltkamp R. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med. 2009, 15:192-199.
88. Liesz A., Zhou W., Na S.Y., Hammerling G.J., Garbi N., Karcher S., Mracsko E., Backs J., Rivest S., Veltkamp R. Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. J. Neurosci. 2013, 33:17350-17362.
89. Littman D.R., Rudensky A.Y. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 2010, 140:845-858.
90. Liu Y., Teige I., Birnir B., Issazadeh-Navikas S. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat. Med. 2006, 12:518-525.
91. Liu J., Johnson T.V., Lin J., Ramirez S.H., Bronich T.K., Caplan S., Persidsky Y., Gendelman H.E., Kipnis J. T cell independent mechanism for copolymer-1-induced neuroprotection. Eur. J. Immunol. 2007, 37:3143-3154.
92. Liu J., Gong N., Huang X., Reynolds A.D., Mosley R.L., Gendelman H.E. Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration. J. Immunol. 2009, 182:3855-3865.
93. Liu M., Zhao J., Liang H., Bian X. Vaccination with dendritic cells pulsed with homogenate protein of spinal cord promotes functional recovery from spinal cord injury in mice. Spinal Cord 2009, 47:360-366.
94. Liu H.N., Tjostheim S., Dasilva K., Taylor D., Zhao B., Rakhit R., Brown M., Chakrabartty A., McLaurin J., Robertson J. Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis. J. Neurosci. 2012, 32:8791-8799.
95. Lobello K., Ryan J.M., Liu E., Rippon G., Black R. Targeting Beta amyloid: a clinical review of immunotherapeutic approaches in Alzheimer's disease. Int. J. Alzheimers Dis. 2012, 2012:628070.
96. Lopez-Vales R., Garcia-Alias G., Fores J., Udina E., Gold B.G., Navarro X., Verdu E. FK 506 reduces tissue damage and prevents functional deficit after spinal cord injury in the rat. J. Neurosci. Res. 2005, 81:827-836.
97. Lowther D.E., Hafler D.A. Regulatory T cells in the central nervous system. Immunol. Rev. 2012, 248:156-169.
98. Lu H.Z., Xu L., Zou J., Wang Y.X., Ma Z.W., Xu X.M., Lu P.H. Effects of autoimmunity on recovery of function in adult rats following spinal cord injury. Brain Behav. Immun. 2008, 22:1217-1230.
99. Lu H.Z., Wang Y.X., Zhou J.S., Wang F.C., Hu J.G. Cyclosporin A increases recovery after spinal cord injury but does not improve myelination by oligodendrocyte progenitor cell transplantation. BMC Neurosci. 2010, 11:127.
100. Luchetti S., Beck K.D., Galvan M.D., Silva R., Cummings B.J., Anderson A.J. Comparison of immunopathology and locomotor recovery in C57BL/6, BUB/BnJ, and NOD-SCID mice after contusion spinal cord injury. J. Neurotrauma 2010, 27:411-421.
101. Lund F.E., Randall T.D. Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat. Rev. Immunol. 2010, 10:236-247.
102. Mackay F., Silveira P.A., Brink R. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. Curr. Opin. Immunol. 2007, 19:327-336.
103. Madsen J.R., MacDonald P., Irwin N., Goldberg D.E., Yao G.L., Meiri K.F., Rimm I.J., Stieg P.E., Benowitz L.I. Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats. Exp. Neurol. 1998, 154:673-683.
104. Martinez-Pasamar S., Abad E., Moreno B., Velez de Mendizabal N., Martinez-Forero I., Garcia-Ojalvo J., Villoslada P. Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity. BMC Syst. Biol. 2013, 7:34.
105. Martinon S., Garcia E., Flores N., Gonzalez I., Ortega T., Buenrostro M., Reyes R., Fernandez-Presas A.M., Guizar-Sahagun G., Correa D., Ibarra A. Vaccination with a neural-derived peptide plus administration of glutathione improves the performance of paraplegic rats. Eur. J. Neurosci. 2007, 26:403-412.
106. Martinon S., Garcia E., Gutierrez-Ospina G., Mestre H., Ibarra A. Development of protective autoimmunity by immunization with a neural-derived peptide is ineffective in severe spinal cord injury. PLoS One 2012, 7:e32027.
107. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296:301-305.
108. McMahon S.S., Albermann S., Rooney G.E., Moran C., Hynes J., Garcia Y., Dockery P., O'Brien T., Windebank A.J., Barry F.P. Effect of cyclosporin A on functional recovery in the spinal cord following contusion injury. J. Anat. 2009, 215:267-279.
109. Meininger V., Drory V.E., Leigh P.N., Ludolph A., Robberecht W., Silani V. Glatiramer acetate has no impact on disease progression in ALS at 40mg/day: a double- blind, randomized, multicentre, placebo-controlled trial. Amyotroph. Lateral Scler. 2009, 10:378-383.
110. Meyer-Luehmann M., Mora J.R., Mielke M., Spires-Jones T.L., de Calignon A., von Andrian U.H., Hyman B.T. T cell mediated cerebral hemorrhages and microhemorrhages during passive Abeta immunization in APPPS1 transgenic mice. Mol. Neurodegeneration 2011, 6:22.
111. Mizrachi Y., Ohry A., Aviel A., Rozin R., Brooks M.E., Schwartz M. Systemic humoral factors participating in the course of spinal cord injury. Paraplegia 1983, 21:287-293.
112. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 1999, 5:49-55.
113. Moalem G., Gdalyahu A., Shani Y., Otten U., Lazarovici P., Cohen I.R., Schwartz M. Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J. Autoimmun. 2000, 15:331-345.
114. Morgan D. Immunotherapy for Alzheimer's disease. J. Intern. Med. 2011, 269:54-63.
115. Muhallab S., Lundberg C., Gielen A.W., Lidman O., Svenningsson A., Piehl F., Olsson T. Differential expression of neurotrophic factors and inflammatory cytokines by myelin basic protein-specific and other recruited T cells infiltrating the central nervous system during experimental autoimmune encephalomyelitis. Scand. J. Immunol. 2002, 55:264-273.
116. Nitsch R., Pohl E.E., Smorodchenko A., Infante-Duarte C., Aktas O., Zipp F. Direct impact of T cells on neurons revealed by two-photon microscopy in living brain tissue. J. Neurosci. 2004, 24:2458-2464.
117. Norimatsu Y., Ohmori T., Kimura A., Madoiwa S., Mimuro J., Seichi A., Yatomi Y., Hoshino Y., Sakata Y. FTY720 improves functional recovery after spinal cord injury by primarily nonimmunomodulatory mechanisms. Am. J. Pathol. 2012, 180:1625-1635.
118. Nottingham S., Knapp P., Springer J. FK506 treatment inhibits caspase-3 activation and promotes oligodendroglial survival following traumatic spinal cord injury. Exp. Neurol. 2002, 177:242-251.
119. Olsson T., Sun J.B., Solders G., Xiao B.G., Hojeberg B., Ekre H.P., Link H. Autoreactive T and B cell responses to myelin antigens after diagnostic sural nerve biopsy. J. Neurol. Sci. 1993, 117:130-139.
120. Palladini G., Grossi M., Maleci A., Lauro G.M., Guidetti B. Immunocomplexes in rat and rabbit spinal cord after injury. Exp. Neurol. 1987, 95:639-651.
121. Peterson S.L., Anderson A.J. Complement and spinal cord injury: Traditional and non-traditional aspects of complement cascade function in the injured spinal cord microenvironment. Exp. Neurol. 2014, 258:35-47. (in this issue).
122. Popovich P.G., Jones T.B. Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol. Sci. 2003, 24:13-17.
123. Popovich P.G., Stokes B.T., Whitacre C.C. Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system POPOVICH1996A. J. Neurosci. Res. 1996, 45:349-363.
124. Potas J.R., Zheng Y., Moussa C., Venn M., Gorrie C.A., Deng C., Waite P.M. Augmented locomotor recovery after spinal cord injury in the athymic nude rat. J. Neurotrauma 2006, 23:660-673.
125. Prochazka M., Voltnerova M., Stefan J. Studies of immunologic reactions after brain injury. II. Antibodies against brain tissue lipids after blunt head injury in man. Int. Surg. 1971, 55:322-326.
126. Qian S., Tang Y., Cheng L., Sun X., Tian J., Zhou C. Interaction of copolymer-1-activated T cells and microglia in RGC protection. Clin. Exp. Ophthalmol. 2013, 41(9):881-890.
127. Reynolds A.D., Stone D.K., Hutter J.A., Benner E.J., Mosley R.L., Gendelman H.E. Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease. J. Immunol. 2010, 184:2261-2271.
128. Rodriguez M., Lennon V.A. Immunoglobulins promote remyelination in the central nervous system. Ann. Neurol. 1990, 27:12-17.
129. Rodriguez M., Lennon V.A., Benveniste E.N., Merrill J.E. Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. J. Neuropathol. Exp. Neurol. 1987, 46:84-95.
130. Rodriguez M., Miller D.J., Lennon V.A. Immunoglobulins reactive with myelin basic protein promote CNS remyelination. Neurology 1996, 46:538-545.
131. Rommer P., Dudesek A., Stuve O., Zettl U. Monoclonal antibodies in treatment of multiple sclerosis. Clin. Exp. Immunol. 2014, 175(3):373-384.
132. Rowland J.W., Hawryluk G.W., Kwon B., Fehlings M.G. Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg. Focus 2008, 25:E2.
133. Rudehill S., Muhallab S., Wennersten A., von Gertten C., Al Nimer F., Sandberg-Nordqvist A.C., Holmin S., Mathiesen T. Autoreactive antibodies against neurons and basal lamina found in serum following experimental brain contusion in rats. Acta Neurochir. 2006, 148:199-205. (discussion 205).
134. Saltzman J.W., Battaglino R.A., Salles L., Jha P., Sudhakar S., Garshick E., Stott H.L., Zafonte R., Morse L.R. B-cell maturation antigen, a proliferation-inducing ligand, and B-cell activating factor are candidate mediators of spinal cord injury-induced autoimmunity. J. Neurotrauma 2013, 30:434-440.
135. Sanchez-Guajardo V., Annibali A., Jensen P.H., Romero-Ramos M. alpha-Synuclein vaccination prevents the accumulation of parkinson disease-like pathologic inclusions in striatum in association with regulatory T cell recruitment in a rat model. J. Neuropathol. Exp. Neurol. 2013, 72:624-645.
136. Saunders J.A., Estes K.A., Kosloski L.M., Allen H.E., Dempsey K.M., Torres-Russotto D.R., Meza J.L., Santamaria P.M., Bertoni J.M., Murman D.L., Ali H.H., Standaert D.G., Mosley R.L., Gendelman H.E. CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease. J. Neuroimmune Pharmacol. 2012, 7:927-938.
137. Schmetterer K.G., Neunkirchner A., Pickl W.F. Naturally occurring regulatory T cells: markers, mechanisms, and manipulation. FASEB J. 2012, 26:2253-2276.
138. Schori H., Kipnis J., Yoles E., WoldeMussie E., Ruiz G., Wheeler L.A., Schwartz M. Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:3398-3403.
139. Schwab J.M., Zhang Y., Kopp M.A., Brommer B., Popovich P.G. The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury. Exp. Neurol. 2014, 258:121-129. (in this issue).
140. Schwartz M. Protective autoimmunity as a T-cell response to central nervous system trauma: prospects for therapeutic vaccines. Prog. Neurobiol. 2001, 65:489-496.
141. Schwartz M., Kipnis J. Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases. J. Neurol. Sci. 2005, 233:163-166.
142. Schwartz M., Ziv Y. Immunity to self and self-maintenance: a unified theory of brain pathologies. Trends Immunol. 2008, 29:211-219.
143. Scorisa J.M., Zanon R.G., Freria C.M., de Oliveira A.L. Glatiramer acetate positively influences spinal motoneuron survival and synaptic plasticity after ventral root avulsion. Neurosci. Lett. 2009, 451:34-39.
144. Serpe C.J., Coers S., Sanders V.M., Jones K.J. CD4+ T, but not CD8+ or B, lymphocytes mediate facial motoneuron survival after facial nerve transection. Brain Behav. Immun. 2003, 17:393-402.
145. Shaked I., Porat Z., Gersner R., Kipnis J., Schwartz M. Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system. J. Neuroimmunol. 2004, 146:84-93.
146. Shechter R., London A., Varol C., Raposo C., Cusimano M., Yovel G., Rolls A., Mack M., Pluchino S., Martino G., Jung S., Schwartz M. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med. 2009, 6:e1000113.
147. Sicotte M., Tsatas O., Jeong S.Y., Cai C.Q., He Z., David S. Immunization with myelin or recombinant Nogo-66/MAG in alum promotes axon regeneration and sprouting after corticospinal tract lesions in the spinal cord. Mol. Cell. Neurosci. 2003, 23:251-263.
148. Sroga J.M., Jones T.B., Kigerl K.A., McGaughy V.M., Popovich P.G. Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J. Comp. Neurol. 2003, 462:223-240.
149. Stebbings R., Poole S., Thorpe R. Safety of biologics, lessons learnt from TGN1412. Curr. Opin. Biotechnol. 2009, 20:673-677.
150. Stefanova I., Dorfman J.R., Germain R.N. Self-recognition promotes the foreign antigen sensitivity of naive T lymphocytes. Nature 2002, 420:429-434.
151. Steinman L. A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:2253-2256.
152. Steward O., Popovich P.G., Dietrich W.D., Kleitman N. Replication and reproducibility in spinal cord injury research. Exp. Neurol. 2012, 233:597-605.
153. Tabira T. Immunization therapy for Alzheimer disease: a comprehensive review of active immunization strategies. Tohoku J. Exp. Med. 2010, 220:95-106.
154. Takeuchi S., Fujiwara N., Ido A., Oono M., Takeuchi Y., Tateno M., Suzuki K., Takahashi R., Tooyama I., Taniguchi N., Julien J.P., Urushitani M. Induction of protective immunity by vaccination with wild-type apo superoxide dismutase 1 in mutant SOD1 transgenic mice. J. Neuropathol. Exp. Neurol. 2010, 69:1044-1056.
155. Toll E.C., Seifalian A.M., Birchall M.A. The role of immunophilin ligands in nerve regeneration. Regen. Med. 2011, 6:635-652.
156. Tyor W.R., Avgeropoulos N., Ohlandt G., Hogan E.L. Treatment of spinal cord impact injury in the rat with transforming growth factor-beta. J. Neurol. Sci. 2002, 200:33-41.
157. Vaughn C.N., Iafrate J.L., Henley J.B., Stevenson E.K., Shlifer I.G., Jones T.B. Cellular neuroinflammation in a lateral forceps compression model of spinal cord injury. Anat. Rec. 2013, 296:1229-1246.
158. Wang D.D., Zhao Y.F., Wang G.Y., Sun B., Kong Q.F., Zhao K., Zhang Y., Wang J.H., Liu Y.M., Mu L.L., Wang D.S., Li H.L. IL-17 potentiates neuronal injury induced by oxygen-glucose deprivation and affects neuronal IL-17 receptor expression. J. Neuroimmunol. 2009, 212:17-25.
159. Wang Y., Wang K., Chao R., Li J., Zhou L., Ma J., Yan J. Neuroprotective effect of vaccination with autoantigen-pulsed dendritic cells after spinal cord injury. J. Surg Res. 2012, 176:281-292.
160. Wang K., Chao R., Guo Q.N., Liu M.Y., Liang H.P., Liu P., Zhao J.H. Expressions of some neurotrophins and neurotrophic cytokines at site of spinal cord injury in mice after vaccination with dendritic cells pulsed with homogenate proteins. Neuroimmunomodulation 2013, 20:87-98.
161. Wei Y., Yemisci M., Kim H.H., Yung L.M., Shin H.K., Hwang S.K., Guo S., Qin T., Alsharif N., Brinkmann V., Liao J.K., Lo E.H., Waeber C. Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann. Neurol. 2011, 69:119-129.
162. Wiendl H., Gross C.C. Modulation of IL-2Ralpha with daclizumab for treatment of multiple sclerosis. Nat. Rev. Neurol. 2013, 9:394-404.
163. Willenborg D.O., Staten E.A., Eidelberg E. Studies on cell-mediated hypersensitivity to neural antigens after experimental spinal cord injury. Exp. Neurol. 1977, 54:383-392.
164. Wu B., Matic D., Djogo N., Szpotowicz E., Schachner M., Jakovcevski I. Improved regeneration after spinal cord injury in mice lacking functional T- and B-lymphocytes. Exp. Neurol. 2012, 237:274-285.
165. Wucherpfennig K.W., Zhang J., Witek C., Matsui M., Modabber Y., Ota K., Hafler D.A. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J. Immunol. 1994, 152:5581-5592.
166. Xin J., Mesnard N.A., Beahrs T., Wainwright D.A., Serpe C.J., Alexander T.D., Sanders V.M., Jones K.J. CD4+ T cell-mediated neuroprotection is independent of T cell-derived BDNF in a mouse facial nerve axotomy model. Brain Behav. Immun. 2012, 26:886-890.
167. Yarom Y., Naparstek Y., Lev-Ram V., Holoshitz J., Ben Nun A., Cohen I.R. Immunospecific inhibition of nerve conduction by T lymphocytes reactive to basic protein of myelin. Nature 1983, 303:246-247.
168. Yogev N., Frommer F., Lukas D., Kautz-Neu K., Karram K., Ielo D., von Stebut E., Probst H.C., van den Broek M., Riethmacher D., Birnberg T., Blank T., Reizis B., Korn T., Wiendl H., Jung S., Prinz M., Kurschus F.C., Waisman A. Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells. Immunity 2012, 37:264-275.
169. Yoles E., Hauben E., Palgi O., Agranov E., Gothilf A., Cohen A., Kuchroo V., Cohen I.R., Weiner H., Schwartz M. Protective autoimmunity is a physiological response to CNS trauma. J. Neurosci. 2001, 21:3740-3748.
170. Yong V.W. Differential mechanisms of action of interferon-beta and glatiramer aetate in MS. Neurology 2002, 59:802-808.
171. Yong J., Lacan G., Dang H., Hsieh T., Middleton B., Wasserfall C., Tian J., Melega W.P., Kaufman D.L. BCG vaccine-induced neuroprotection in a mouse model of Parkinson's disease. PLoS One 2011, 6:e16610.
172. Yu W.R., Fehlings M.G. Fas/FasL-mediated apoptosis and inflammation are key features of acute human spinal cord injury: implications for translational, clinical application. Acta Neuropathol. 2011, 122:747-761.
173. Yu P., Huang L., Zou J., Zhu H., Wang X., Yu Z., Xu X.M., Lu P.H. DNA vaccine against NgR promotes functional recovery after spinal cord injury in adult rats. Brain Res. 2007, 1147:66-76.
174. Yu C.Y., Ng G., Liao P. Therapeutic antibodies in stroke. Transl. Stroke Res. 2013, 4:477-483.
175. Yu Y.Z., Wang S., Bai J.Y., Zhao M., Chen A., Wang W.B., Chang Q., Liu S., Qiu W.Y., Pang X.B., Xu Q., Sun Z.W. Effective DNA epitope chimeric vaccines for Alzheimer's disease using a toxin-derived carrier protein as a molecular adjuvant. Clin. Immunol. 2013, 149:11-24.
176. YuseffM.I., Pierobon P., Reversat A., Lennon-Dumenil A.M. How B cells capture, process and present antigens: a crucial role for cell polarity. Nat. Rev. Immunol. 2013, 13:475-486.
177. Zajarias-Fainsod D., Carrillo-Ruiz J., Mestre H., Grijalva I., Madrazo I., Ibarra A. Autoreactivity against myelin basic protein in patients with chronic paraplegia. Eur. Spine J. 2012, 21:964-970.
178. Zhou Z., Peng X., Fink D.J., Mata M. HSV-mediated transfer of artemin overcomes myelin inhibition to improve outcome after spinal cord injury. Mol. Ther. 2009, 17:1173-1179.
179. Zhou Z., Peng X., Insolera R., Fink D.J., Mata M. IL-10 promotes neuronal survival following spinal cord injury. Exp. Neurol. 2009, 220:183-190.
180. Zhou Z., Peng X., Insolera R., Fink D.J., Mata M. Interleukin-10 provides direct trophic support to neurons. J. Neurochem. 2009, 110:1617-1627.